Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed April 10, 2026.
Kenvue is a global consumer health company that operates as the independent successor to the Johnson & Johnson Consumer Health division. It manages a portfolio of iconic brands in categories such as self-care, skin health, and essential health, including Tylenol, Neutrogena, and Listerine. Following its 2023 spinoff and IPO, it became the world's largest pure-play consumer health company by revenue.
Optimly has not yet published enough evidence to assess how often AI assistants recommend Kenvue Johnson Johnson Spin Off.
Optimly has not yet published a supported competitor set for Kenvue Johnson Johnson Spin Off.
Official website: https://kenvue.com/
Last analyzed: April 10, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile